Development Of An Antibody-targeted Drug/miRNA/peptide Delivery System For Effective Prevention Of Restenosis
Funder
National Health and Medical Research Council
Funding Amount
$319,064.00
Summary
The re-blocking of vessels after surgery occurs up to 50% of patients, and none of the preventive approaches are cost-effective and safe enough. This project aims to develop a nano-scaled therapeutics delivering combination therapies to effectively prevent the re-blockage after surgery. If successful, this research will present a whole new range of therapeutic agent that prevents the patient from developing clots after surgery, improving the productivity and health of patients with reduced cost.